发布求助
文献互助 智能选刊 最新文献

Journal of Cancer Therapy and Research最新文献

筛选
英文 中文
Cancer Chemotherapy-Induced Adverse Drug Reactions: A Prospective Study Of Role Of Socio-Demographic Factors 癌症化疗引起的药物不良反应:社会人口因素作用的前瞻性研究
Journal of Cancer Therapy and Research Pub Date : 2022-01-01 DOI: 10.52793/jctr.2022.2(1)-13
N. Gupte, Seema Gupta, Dinesh Kumar, Rahul Sharma
{"title":"Cancer Chemotherapy-Induced Adverse Drug Reactions: A Prospective Study Of Role Of Socio-Demographic Factors","authors":"N. Gupte, Seema Gupta, Dinesh Kumar, Rahul Sharma","doi":"10.52793/jctr.2022.2(1)-13","DOIUrl":"https://doi.org/10.52793/jctr.2022.2(1)-13","url":null,"abstract":"Background: Cancer chemotherapy is known to be accompanied by adverse drug reactions (ADRs). There is a paucity of documented studies concerning the factors predisposing to these ADRs in the English medical literature. Objective: To evaluate the role played by socio-demographic factors in predisposition to ADRs in patients on cancer chemotherapy. Material and Methods: In this prospective and observational study, outcome of relationship between socio-demographic factors and ADRs occurring in patients receiving cancer chemotherapy in a regional oncology center in Jammu and Kashmir, India over a period of one year was studied. Results: Overall, 90% of the 102 cancer patients expressed ADRs to chemotherapy. As many as 268 ADRs were reported in the study participants. The most common adverse effects were alopecia, nausea, constipation and vomiting. The mean age of the participants was 46.84 ± 15.18 years. The mean age of","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"577 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133910900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent Leiomyosarcoma Is A Rare Commodity In Penile Cancer: A Review And Report 复发性平滑肌肉瘤是阴茎癌中一种罕见的疾病:综述与报道
Journal of Cancer Therapy and Research Pub Date : 2022-01-01 DOI: 10.52793/jctr.2022.2(1)-16
P. Jayakumar, Manish, M. Ray
{"title":"Recurrent Leiomyosarcoma Is A Rare Commodity In Penile Cancer: A Review And Report","authors":"P. Jayakumar, Manish, M. Ray","doi":"10.52793/jctr.2022.2(1)-16","DOIUrl":"https://doi.org/10.52793/jctr.2022.2(1)-16","url":null,"abstract":"Recurrent Leiomyosarcoma is a Rare Commodity in Penile Cancer: A Review and Report. Abstract Squamous cell carcinoma constitutes approximately 95% of penile cancer. Sarcomas of penis are rarer among them. Leiomyosarcoma is one of the extremely rare sarcoma of penis. To best of our knowledge and literature review, only few cases have been reported world-wide so far. We are presenting this uncommon case of recurrent leiomyosarcoma of penis in a 37 year male patient which was diagnosed with microscopy with its characteristic immunohistochemistry along with a concise review.","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134646808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain Tumor (Glioma), Impact Of Immunohistochemistry In Prognosis And Prediction Radiation Oncologist Perspective 脑肿瘤(胶质瘤)，免疫组化在预后和预测放射肿瘤学观点中的影响
Journal of Cancer Therapy and Research Pub Date : 2022-01-01 DOI: 10.52793/jctr.2022.2(1)-14
Major MQ Baig, Ansu Goel
{"title":"Brain Tumor (Glioma), Impact Of Immunohistochemistry In Prognosis And Prediction Radiation Oncologist Perspective","authors":"Major MQ Baig, Ansu Goel","doi":"10.52793/jctr.2022.2(1)-14","DOIUrl":"https://doi.org/10.52793/jctr.2022.2(1)-14","url":null,"abstract":"Primary brain tumors are rare and uncommon tumors comprising only 1.6 percent of cancers, although Metastatic brain tumors are more common entity. Primary CNS neoplasm’s are a challenging group of tumors to treat given their varied patterns of behavior and subsequent varied clinical outcomes. This chapter will focus on the treatment of both adult low-grade gliomas (LGGs) and adult high-grade gliomas (HGGs), with an emphasis on radiation therapy techniques, Signs and symptoms of intracranial tumors depends upon types and histology as well as grade of tumors, Some tumors causes problems by their intracranial extension only for example Glioms, Menangiomas, Pituitary tumors other brain tumors like Primary CNS Lymphomas, Germ cell tumors as well as Primitive Neuroendocrine tumors (PNET ) have strong prediction of leptomeningeal spread, among all primary brain tumor Gioblastoma multiforme (GBM) is the most common primary brain tumor and one of the most lethal in nature due to its infiltrative nature because of this GBM overall survival with surgical resection alone is 3 to 6 month only but if we add adjuvant radiotherapy after surgery its overall survival extends up to 1 year furthermore if we add alkalizing agents chemotherapy its overall survival goes up to 1.5 years.","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"71 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123170542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications Of Chemotherapy For Breast Cancer 乳腺癌化疗的并发症
Journal of Cancer Therapy and Research Pub Date : 2022-01-01 DOI: 10.52793/jctr.2022.2(1)-12
{"title":"Complications Of Chemotherapy For Breast Cancer","authors":"","doi":"10.52793/jctr.2022.2(1)-12","DOIUrl":"https://doi.org/10.52793/jctr.2022.2(1)-12","url":null,"abstract":"Breast cancer is a non-communicable disease which becomes the second leading cause of death all over the world for women. Day by day the rate of this disease is increasing because of the risk factors related to lifestyle. Chemotherapy is a common treatment for breast cancer patients. Chemotherapy treatment depends on stage of cancer, patient’s age, menopausal stage, hormone receptor status and lymph node involvement as a patient has the chance to face some complications to take this treatment. In this treatment, drugs are used to treat cancerous cells. And because of these anticancer drugs patients experience many complications. Though there have some complication patient should be aware about those before going to take breast cancer chemotherapy treatment which will help them to follow proper diagnosis and treatment guidelines.","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132592009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Covid Cancer Covid癌症
Journal of Cancer Therapy and Research Pub Date : 2022-01-01 DOI: 10.52793/jctr.2022.2(1)-18
P. Cusack
{"title":"Covid Cancer","authors":"P. Cusack","doi":"10.52793/jctr.2022.2(1)-18","DOIUrl":"https://doi.org/10.52793/jctr.2022.2(1)-18","url":null,"abstract":"","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"98 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124681969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention Of Human Papillomavirus Associated Cancer 人类乳头瘤病毒相关癌症的预防
Journal of Cancer Therapy and Research Pub Date : 2021-08-24 DOI: 10.52793/jctr.2021.1(1)-02
S. Sarkar, Siddheesh Rajpurohit, S. Chauhan, Ashutosh Kumar Singh
{"title":"Prevention Of Human Papillomavirus Associated Cancer","authors":"S. Sarkar, Siddheesh Rajpurohit, S. Chauhan, Ashutosh Kumar Singh","doi":"10.52793/jctr.2021.1(1)-02","DOIUrl":"https://doi.org/10.52793/jctr.2021.1(1)-02","url":null,"abstract":"HPV (Human papillomavirus) infects epithelial cells, and their replication cycle is intimately linked to epithelial differentiation. A subset of mucosal-infective HPVs, also known as ‘high risk’ (HR) HPVs, causes cervical disease and could be classified as low or high grade. The HR-HPVs related infection can affect at any stage of life, or several individuals may experience during their lifetime. Our robust immune system plays a crucial role in recognizing and clearing the virus, but sometimes we need potent therapy to eliminate or prevent it. This review deals with the prevention of HPV from attacking host cells, and the methods may include vaccination or acute treatment. The short overview also enlightens the pathogenesis, mode of infection, and evidence-based prevention strategies of the HPV and associated cancer.","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130743054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Of Albino Rats With Oltipraz (4-MethyL-5-PyrazinyL-3H-1,2-Dithiole-3-Thione Protects Against Doxorubicin-Induced Cardiotoxicity Oltipraz(4-甲基-5-吡嗪基- 3h -1,2-二硫基-3-硫酮)治疗白化大鼠抗阿霉素诱导的心脏毒性
Journal of Cancer Therapy and Research Pub Date : 2021-07-20 DOI: 10.52793/jctr.2022.2(1)-11
G. Jagetia, Kanan Ramthianghlima
{"title":"Treatment Of Albino Rats With Oltipraz (4-MethyL-5-PyrazinyL-3H-1,2-Dithiole-3-Thione Protects Against Doxorubicin-Induced Cardiotoxicity","authors":"G. Jagetia, Kanan Ramthianghlima","doi":"10.52793/jctr.2022.2(1)-11","DOIUrl":"https://doi.org/10.52793/jctr.2022.2(1)-11","url":null,"abstract":"Doxorubicin is an anthracycline group of antibiotics that is frequently used in the treatment of various human neoplasias clinically. However, its adverse effect on the human heart is of major concern and limits its full clinical utilization. The present study was undertaken to alleviate the doxorubicin-induced myocardial toxicity by oltipraz an Nrf-2 inducer in albino rats. The albino rats were orally administered with 10 mg/kg body weight of oltipraz daily for three days before treatment with 15 mg/kg body weight of doxorubicin. The doxorubicin-induced myocardial stress indicated by an increase in the CK-MB activity, and lipid peroxidation accompanied by a reduction in the glutathione, glutathione-s-transferase, catalase and superoxide dismutase in the rat heart. The administration of 10 mg/kg oltipraz for three days before doxorubicin treatment reduced the CK-MB activity and lipid peroxidation significantly followed by the significant elevation in the activities of glutathione-s-transferase, catalase and superoxide dismutase and glutathione in the rat heart. Our study demonstrates that oltipraz an Nrf-2 inducer reduced doxorubicin-induced myocardial stress in the rats.","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130409592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covid-19 Times, When Truly “Every Drop Counts” Covid-19时代，真正的“每一滴都很重要”
Journal of Cancer Therapy and Research Pub Date : 2021-01-01 DOI: 10.52793/jctr.2021.1(1)-05
M. Hassan, Housam Eddine Al Hariri, Rola Kwayess, Julie Breish, Lamees Kawam, Nada Youssef, A. Bizri
{"title":"Covid-19 Times, When Truly “Every Drop Counts”","authors":"M. Hassan, Housam Eddine Al Hariri, Rola Kwayess, Julie Breish, Lamees Kawam, Nada Youssef, A. Bizri","doi":"10.52793/jctr.2021.1(1)-05","DOIUrl":"https://doi.org/10.52793/jctr.2021.1(1)-05","url":null,"abstract":"Coronavirus disease 2019 (Covid-19) had tremendous effects on various health care sectors all over the world, and as the pandemic continues, the blood donation sector is especially affected. During unusual times, where risk of contracting the novel Corona virus (SARS-CoV-2) is very likely, it can be seen why blood donations have decreased. In this article we will discuss why and how the blood donation sector was affected during the Covid-19 pandemic in various countries around the world and will propose our medical center’s solution for the potential shortages in blood and blood products supplies.","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129377470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatoduodeno Pancreatectomy For Biliary Tract Cancers: Report Of 5 Cases And Review Of The Literature 肝十二指肠胰切除术治疗胆道肿瘤5例报告并文献复习
Journal of Cancer Therapy and Research Pub Date : 2021-01-01 DOI: 10.52793/jctr.2021.1(1)-10
S. Berkane, Fatiha Ali Benamara, A. Bennani, N. Annane, Faiza Taib, Salim Belkherchi
{"title":"Hepatoduodeno Pancreatectomy For Biliary Tract Cancers: Report Of 5 Cases And Review Of The Literature","authors":"S. Berkane, Fatiha Ali Benamara, A. Bennani, N. Annane, Faiza Taib, Salim Belkherchi","doi":"10.52793/jctr.2021.1(1)-10","DOIUrl":"https://doi.org/10.52793/jctr.2021.1(1)-10","url":null,"abstract":"Hepatoduodenopancreatectomy (HDP) is a major intervention and is recommended in surgery for biliary tract cancer. We report 5 observations of patients treated by this technique for cancer. Observation: These are 3 women and 2 men, with an average age of 45 years (40-49 years) operated for cancer of the gall bladder in 3 cases, cancer of the pancreas","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"162 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122476359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Integration Of Palliative Care In The Management Of Patients With Carcinoma Cervix- Isn’t It Time To Switch Gears To A Patient Centric Treatment Approach? 姑息治疗在宫颈癌患者管理中的早期整合——是时候转向以患者为中心的治疗方法了吗?
Journal of Cancer Therapy and Research Pub Date : 2021-01-01 DOI: 10.52793/jctr.2021.1(1)-04
N. Radhakrishna
{"title":"Early Integration Of Palliative Care In The Management Of Patients With Carcinoma Cervix- Isn’t It Time To Switch Gears To A Patient Centric Treatment Approach?","authors":"N. Radhakrishna","doi":"10.52793/jctr.2021.1(1)-04","DOIUrl":"https://doi.org/10.52793/jctr.2021.1(1)-04","url":null,"abstract":"Carcinoma cervix is a common malignancy affecting a vast majority of women, especially in low-and middle-income nations. These women have a large magnitude of symptom burden right from diagnosis until completion of treatment and beyond. While oncological treatment modalities remain predominantly disease-centric, palliative care (PC) plays a multidimensional role involving communication, management of physical, psychological, social, spiritual issues and end-of-life care. In order to improve the patient’s satisfaction, treatment compliance and quality of life, PC must be commenced early and integrated within the framework of multi-modality management of carcinoma cervix. Patients with advanced cervical cancer who become terminally ill require intensification of PC and a gradual transition into hospice care. Oncology teams must thus, work in tandem with palliative care teams to ensure holistic management of women suffering from cervical cancer.","PeriodicalId":325896,"journal":{"name":"Journal of Cancer Therapy and Research","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133341240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信